Skip to main content

Table 7 Comorbidity profile of late-diagnosed adult PKU patients in 2015 in Germany

From: Clinical burden of illness in patients with phenylketonuria (PKU) and associated comorbidities - a retrospective study of German health insurance claims data

ICD-10-GM code

Description

Late-diagnosed PKU patients (n = 216)

%

Control group (n = 2,160)

%

PR (95% CI)

I10

Essential (primary) hypertension

61.1

58.4

1.05 (0.94, 1.17)

E78

Disorders of lipoprotein metabolism and other lipidemias

52.3

40.4

1.30 (1.13, 1.49) a

M54

Dorsalgia

42.1

36.1

1.17 (0.99, 1.38)

H52

Disorders of refraction and accommodation

38.0

33.1

1.15 (0.96, 1.37)

Z12

Encounter for screening for malignant neoplasms

28.2

30.0

0.94 (0.75, 1.18)

I25

Chronic ischemic heart disease

25.9

15.6

1.67 (1.30, 2.13) a

E11

Type 2 diabetes mellitus

25.5

19.6

1.30 (1.02, 1.65) a

Z25

Need for immunization against other single viral diseases

22.2

20.4

1.09 (0.84, 1.42)

M17

Osteoarthritis of knee

21.3

17.2

1.24 (0.94, 1.63)

Z00

Encounter for general exam without complaint, suspected or reported dx

20.8

20.2

1.03 (0.79, 1.36)

N95

Menopausal and other perimenopausal disorders

20.4

14.5

1.40 (1.06, 1.86) a

E04

Other nontoxic goiter

19.9

14.7

1.35 (1.02, 1.80) a

M47

Spondylosis

19.4

18.8

1.03 (0.78, 1.37)

E66

Overweight and obesity

19.0

14.2

1.34 (0.99, 1.79)

F32

Major depressive disorder, single episode

19.0

15.8

1.20 (0.90, 1.61)

M53

Other and unspecified dorsopathies, not elsewhere classified

19.0

12.6

1.51 (1.12, 2.03) a

Z01

Encounter for other specified exam without complaint, suspected or reported dx

18.5

12.9

1.43 (1.06, 1.94) a

E14

Unspecified diabetes mellitus

18.5

10.7

1.73 (1.28, 2.35) a

E79

Disorders of purine and pyrimidine metabolism

17.6

11.1

1.59 (1.16, 2.17) a

N39

Other disorders of urinary system

17.6

12.5

1.40 (1.03, 1.91) a

Z92

Personal history of medical treatment

17.1

13.0

1.32 (0.97, 1.81)

F45

Somatoform disorders

17.1

14.3

1.20 (0.88, 1.64)

J44

Other chronic obstructive pulmonary disease

16.2

8.2

1.97 (1.41, 2.75) a

J06

Acute upper respiratory infections of multiple and unspecified sites

15.7

12.2

1.29 (0.93, 1.79)

K29

Gastritis and duodenitis

15.7

11.1

1.42 (1.02, 1.98) a

R42

Dizziness and giddiness

14.8

8.3

1.79 (1.26, 2.53) a

I83

Varicose veins of lower extremities

14.8

13.0

1.14 (0.82, 1.60)

Z96

Presence of other functional implants

14.4

14.7

0.97 (0.69, 1.37)

N89

Other noninflammatory disorders of vagina

14.4

10.6

1.35 (0.96, 1.92)

M19

Other and unspecified osteoarthritis

14.4

10.1

1.42 (1.00, 2.01)

H35

Other retinal disorders

13.9

11.3

1.23 (0.86, 1.75)

L30

Other and unspecified dermatitis

13.9

9.0

1.54 (1.08, 2.20) a

I70

Atherosclerosis

13.9

7.6

1.82 (1.26, 2.61) a

J45

Asthma

13.4

6.9

1.93 (1.33, 2.81) a

I50

Heart failure

13.4

8.3

1.61 (1.12, 2.32) a

M21

Other acquired deformities of limbs

13.0

5.0

2.59 (1.75, 3.83) a

E03

Other hypothyroidism

13.0

10.7

1.21 (0.84, 1.75)

N18

Chronic kidney disease

13.0

7.9

1.64 (1.13, 2.38) a

N40

Enlarged prostate

13.0

12.3

1.06 (0.73, 1.52)

K76

Other diseases of liver

12.5

10.6

1.18 (0.82, 1.72)

M16

Osteoarthritis of hip

12.5

8.9

1.41 (0.96, 2.05)

H25

Age-related cataract

12.5

11.2

1.12 (0.77, 1.62)

D22

Melanocytic nevi

12.5

9.4

1.34 (0.92, 1.95)

I49

Other cardiac arrhythmias

12.0

10.0

1.20 (0.82, 1.76)

Z95

Presence of cardiac and vascular implants and grafts

12.0

8.1

1.48 (1.00, 2.18)

M51

Thoracic, thoracolumbar, and lumbosacral intervertebral disc disorders

11.6

12.8

0.91 (0.62, 1.33)

R10

Abdominal and pelvic pain

11.6

10.1

1.14 (0.77, 1.69)

M42

Spinal osteochondrosis

11.6

8.5

1.36 (0.92, 2.01)

H61

Other disorders of external ear

11.6

10.5

1.11 (0.75, 1.63)

  1. aComorbidities that had a significant PR vs the control population